LEP and polycystic ovary syndrome: In a study by Gerli et al. body weight and circulating leptin decreased significantly and HDL concentrations increased significantly in the patients treated with Myo-Ins, compared with the placebo group, providing the first indication that Myo-Ins treatment might possibly reduce the risk of cardiovascular diseases in PCOS women.